Cargando…
Proteomics analysis of potential serum biomarkers for insulin resistance in patients with polycystic ovary syndrome
The aim of the present study was to identify potential serum biomarkers for insulin resistance (IR) in patients with polycystic ovary syndrome (PCOS) by comparing the differences in serum protein expression levels between PCOS patients with and without IR. PCOS patients aged from 18 to 35 years were...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138261/ https://www.ncbi.nlm.nih.gov/pubmed/32323743 http://dx.doi.org/10.3892/ijmm.2020.4522 |
_version_ | 1783518552878219264 |
---|---|
author | Li, Li Zhang, Jing Zeng, Jing Liao, Biling Peng, Xiuhong Li, Tiantian Li, Jieming Tan, Qiuxiao Li, Xiaofang Yang, Ying Chen, Zhijing Liang, Zhijiang |
author_facet | Li, Li Zhang, Jing Zeng, Jing Liao, Biling Peng, Xiuhong Li, Tiantian Li, Jieming Tan, Qiuxiao Li, Xiaofang Yang, Ying Chen, Zhijing Liang, Zhijiang |
author_sort | Li, Li |
collection | PubMed |
description | The aim of the present study was to identify potential serum biomarkers for insulin resistance (IR) in patients with polycystic ovary syndrome (PCOS) by comparing the differences in serum protein expression levels between PCOS patients with and without IR. PCOS patients aged from 18 to 35 years were recruited at Guangdong Women and Children’s Hospital from January, 2013 to February, 2014. A total of 218 PCOS patients were enrolled and divided into the insulin resistance (PCOS-IR) and non-insulin resistance (PCOS-NIR) groups according to their homeostasis model assessment of insulin resistance. Two-dimensional difference gel electrophoresis (2D-DIGE) and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS/MS) techniques were used to identify differences in protein expression levels between the PCOS-IR and PCOS-NIR groups. The present study demonstrated that the total cholesterol (TCH), triglycerides (TG), low-density lipoprotein (LDL), fasting plasma glucose (FPG), 3-h blood glucose (3hBG) and uric acid (UA) levels in the PCOS-IR group were higher than those in the PCOS-NIR group (P<0.05). Between the PCOS-IR and PCOS-NIR groups, a total of 20 differentially expressed protein spots were detected by 2D-DIGE. Among these, 4 proteins, namely afamin, serotransferrin, complement C3 and apolipoprotein C3 (APOC3), were also identified by MALDI-TOF-MS/MS. The alteration of APOC3 was further confirmed by western blot analysis and enzyme-linked immunosorbent assay (ELISA). The present study also confirmed that the expression level of APOC3 was positively associated with the homeostasis model assessment of insulin resistance (HOMA-IR). On the whole, the data indicate that APOC3 may be a potential diagnostic marker for PCOS-IR patients. |
format | Online Article Text |
id | pubmed-7138261 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-71382612020-04-08 Proteomics analysis of potential serum biomarkers for insulin resistance in patients with polycystic ovary syndrome Li, Li Zhang, Jing Zeng, Jing Liao, Biling Peng, Xiuhong Li, Tiantian Li, Jieming Tan, Qiuxiao Li, Xiaofang Yang, Ying Chen, Zhijing Liang, Zhijiang Int J Mol Med Articles The aim of the present study was to identify potential serum biomarkers for insulin resistance (IR) in patients with polycystic ovary syndrome (PCOS) by comparing the differences in serum protein expression levels between PCOS patients with and without IR. PCOS patients aged from 18 to 35 years were recruited at Guangdong Women and Children’s Hospital from January, 2013 to February, 2014. A total of 218 PCOS patients were enrolled and divided into the insulin resistance (PCOS-IR) and non-insulin resistance (PCOS-NIR) groups according to their homeostasis model assessment of insulin resistance. Two-dimensional difference gel electrophoresis (2D-DIGE) and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS/MS) techniques were used to identify differences in protein expression levels between the PCOS-IR and PCOS-NIR groups. The present study demonstrated that the total cholesterol (TCH), triglycerides (TG), low-density lipoprotein (LDL), fasting plasma glucose (FPG), 3-h blood glucose (3hBG) and uric acid (UA) levels in the PCOS-IR group were higher than those in the PCOS-NIR group (P<0.05). Between the PCOS-IR and PCOS-NIR groups, a total of 20 differentially expressed protein spots were detected by 2D-DIGE. Among these, 4 proteins, namely afamin, serotransferrin, complement C3 and apolipoprotein C3 (APOC3), were also identified by MALDI-TOF-MS/MS. The alteration of APOC3 was further confirmed by western blot analysis and enzyme-linked immunosorbent assay (ELISA). The present study also confirmed that the expression level of APOC3 was positively associated with the homeostasis model assessment of insulin resistance (HOMA-IR). On the whole, the data indicate that APOC3 may be a potential diagnostic marker for PCOS-IR patients. D.A. Spandidos 2020-05 2020-03-03 /pmc/articles/PMC7138261/ /pubmed/32323743 http://dx.doi.org/10.3892/ijmm.2020.4522 Text en Copyright: © Li et al. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) License. |
spellingShingle | Articles Li, Li Zhang, Jing Zeng, Jing Liao, Biling Peng, Xiuhong Li, Tiantian Li, Jieming Tan, Qiuxiao Li, Xiaofang Yang, Ying Chen, Zhijing Liang, Zhijiang Proteomics analysis of potential serum biomarkers for insulin resistance in patients with polycystic ovary syndrome |
title | Proteomics analysis of potential serum biomarkers for insulin resistance in patients with polycystic ovary syndrome |
title_full | Proteomics analysis of potential serum biomarkers for insulin resistance in patients with polycystic ovary syndrome |
title_fullStr | Proteomics analysis of potential serum biomarkers for insulin resistance in patients with polycystic ovary syndrome |
title_full_unstemmed | Proteomics analysis of potential serum biomarkers for insulin resistance in patients with polycystic ovary syndrome |
title_short | Proteomics analysis of potential serum biomarkers for insulin resistance in patients with polycystic ovary syndrome |
title_sort | proteomics analysis of potential serum biomarkers for insulin resistance in patients with polycystic ovary syndrome |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138261/ https://www.ncbi.nlm.nih.gov/pubmed/32323743 http://dx.doi.org/10.3892/ijmm.2020.4522 |
work_keys_str_mv | AT lili proteomicsanalysisofpotentialserumbiomarkersforinsulinresistanceinpatientswithpolycysticovarysyndrome AT zhangjing proteomicsanalysisofpotentialserumbiomarkersforinsulinresistanceinpatientswithpolycysticovarysyndrome AT zengjing proteomicsanalysisofpotentialserumbiomarkersforinsulinresistanceinpatientswithpolycysticovarysyndrome AT liaobiling proteomicsanalysisofpotentialserumbiomarkersforinsulinresistanceinpatientswithpolycysticovarysyndrome AT pengxiuhong proteomicsanalysisofpotentialserumbiomarkersforinsulinresistanceinpatientswithpolycysticovarysyndrome AT litiantian proteomicsanalysisofpotentialserumbiomarkersforinsulinresistanceinpatientswithpolycysticovarysyndrome AT lijieming proteomicsanalysisofpotentialserumbiomarkersforinsulinresistanceinpatientswithpolycysticovarysyndrome AT tanqiuxiao proteomicsanalysisofpotentialserumbiomarkersforinsulinresistanceinpatientswithpolycysticovarysyndrome AT lixiaofang proteomicsanalysisofpotentialserumbiomarkersforinsulinresistanceinpatientswithpolycysticovarysyndrome AT yangying proteomicsanalysisofpotentialserumbiomarkersforinsulinresistanceinpatientswithpolycysticovarysyndrome AT chenzhijing proteomicsanalysisofpotentialserumbiomarkersforinsulinresistanceinpatientswithpolycysticovarysyndrome AT liangzhijiang proteomicsanalysisofpotentialserumbiomarkersforinsulinresistanceinpatientswithpolycysticovarysyndrome |